EMEA-000927-PIP01-10-M06
Key facts
Invented name |
Constella
|
Active substance |
linaclotide
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/0216/2021
|
PIP number |
EMEA-000927-PIP01-10-M06
|
Pharmaceutical form(s) |
Capsule, hard
|
Condition(s) / indication(s) |
Treatment of functional constipation
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Allergan Pharmaceuticals International Limited
E-mail: ml-eu_reg_affairs@allergan.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|